Grant Life Sciences to In-License HPV DNA-based Test from AlphaGenics

LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences Inc. (OTC Bulletin Board: GLIF) announced today that it has signed a Memo of Understanding (MOU) with Alphagenics Diaco Biotechnologies S.r.l. (Italy) to exclusively in-license the manufacturing and marketing rights to Alphagenics’ molecular diagnostic test for Human Papilloma Viruses (HPVs) in Greater China and the United States and non-exclusively in Europe, India, Australia and Japan. The Alphagenics HPV test is a DNA-based diagnostic that uses standard molecular diagnostic equipment found in most commercial laboratories.